Ivy Foundation Translational Adult Glioma Grant Award 2021

Ben & Catherine Ivy Foundation
Application or LOI Due Date
March 1, 2021: Application Due Date (Please do not submit before January 1, 2021)
Brief Description

Program Description

The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioma. This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.


  • A PhD, MD or equivalent is required.
  • Only one submission per applicant is permitted every calendar year.
  • Applicants need not be U.S. citizens, but must be employed by a U.S. non-profit academic institution.
  • The Ben & Catherine Ivy Foundation does not discriminate on the basis of race, color, religion, national origin, sex, gender identity, sexual orientation, age, disability or any other legally protected characteristics.

Award Terms

  • $600,000 total, payments received at initiation and completion of project
  • Project duration is 24 months
  • Indirect costs not to exceed 10% (included in award total)

Key Dates

  • March 1, 2021: Application Due Date (Please do not submit before January 1, 2021)
  • May 1, 2021: Selection of Awardees
  • June 15, 2021: Signed Agreements Due
  • July 1, 2021: Award Start Date

Application Information Required

  • Contact Information (name, phone, address, email, and assistant contact information)
  • Project Title
  • Project Description
    • 4 page maximum including graphs, photos, etc.
    • Minimum 10-point font size
  • Principal Investigator’s Biography
    • 6 page maximum
    • NIH Biosketch
  • List of All Current Funding 
    • 50-word project description, affiliated parties, and direct costs per year